首页   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
VDA

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

VDA

结构式 货号 产品名称 CAS号
Verubulin 结构式
BCP09127 Verubulin 827031-83-4
Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme.
Ombrabulin 结构式
BCP07754 奥瑞布林 181816-48-8
Ombrabulin is a synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities.
AZD-6126 结构式
BCP04084 AZD-6126 219923-05-4
AZD6126 was being investigated by AstraZeneca as a VDA (vascular disrupting agent).AZD-6126 is an angiogenesis inhibitor and tubulin inhibitor potentially for the treatment of solid tumours.
BNC105P 结构式
BCP04200 BNC105P 945771-96-0
BNC105P is a benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities.
BNC105 结构式
BCP19547 BNC105 945771-74-4
BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
Verteporfin 结构式
BCP04238 维替泊芬 129497-78-5
Verteporfin, a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy.
Plinabulin 结构式
BCP02849 普那布林 714272-27-2
NPI-2358 (Plinabulin) is a novel vascular disrupting agent (VDA) with an IC50 of 15 nM against HT-29 cells.
DMXAA 结构式
BCP01949 2,5-己酮可可碱 117570-53-3
DMXAA is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively.
2853530910